Related Experiment Video
Updated: Apr 25, 2026
23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
18.4K
[Management of multidrug-resistant tuberculosis]
F Tritar1, H Daghfous1, S Ben Saad1
1Service de pneumologie, hôpital A.-Mami, Ariana, 2080 Tunis, Tunisie.
Revue De Pneumologie Clinique
|August 26, 2014
Summary
Multidrug-resistant tuberculosis (MDR-TB) poses a significant global health challenge due to drug resistance. Treatment is lengthy and complex, with cure rates lower than drug-susceptible TB.
Area of Science:
- Microbiology
- Public Health
- Infectious Diseases
Context:
- Drug-resistant tuberculosis (TB) is a growing global health crisis.
- Multidrug-resistant TB (MDR-TB) is caused by resistance to isoniazid and rifampicin.
- Poor patient adherence is a primary driver of MDR-TB emergence.
Purpose:
- To summarize the challenges and current approaches in managing multidrug-resistant tuberculosis.
- To highlight the complexities of MDR-TB diagnosis and treatment.
- To review the outcomes and mortality associated with MDR-TB.
Summary:
- Rapid diagnostic techniques improve early MDR-TB treatment initiation.
- MDR-TB treatment involves an 8-month intensive phase with 5 drugs (including injectable and fluoroquinolone) and a prolonged maintenance phase.
- Surgery may be considered for localized lesions in patients with adequate cardiorespiratory function.
Impact:
- MDR-TB treatment success rates are lower (60-75%) compared to drug-susceptible TB.
- Extensively drug-resistant TB (XDR-TB) has even poorer outcomes (30-40% cure rate).
- High mortality rates (20-40%, up to 70-90% with HIV co-infection) underscore the severity of MDR-TB.
Keywords:
MDR-TBMultidrug-resistant tuberculosisTraitementTreatmentTuberculoseTuberculose multirésistanteTuberculosisXDR-TBXDR–TBMore Related Videos
Related Concept Videos
01:28Pulmonary Tuberculosis V
974
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
974
01:29Pulmonary Tuberculosis I
1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
01:26Pulmonary Tuberculosis IV
799
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
799
01:25Clinical Significance of Antibiotic Resistance
84
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
84
01:28Pneumonia IV: Management
1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
01:25Mechanism of Antibiotic Resistance in MRSA
202
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
202